Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases (Q36463952)

14 August 2017

1 reference

title

Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases (English)

1 reference

14 August 2017

0 references

1 reference

Ingrid Herr

1

1 reference

14 August 2017

Jesco Pfitzenmaier

series ordinal

2

1 reference

14 August 2017

publication date

1 May 2006

1 reference

Lancet Oncology Commission

14 August 2017

published in

1 reference

14 August 2017

volume

7

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

425-430

1 reference

Glucocorticoid-induced apoptosis in lymphocytes

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Effects of corticosteroid use on treatment of solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Advances in prostate cancer chemotherapy: a new era begins.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoid regulation of the inflammatory response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Fifty years of experience with cortisone therapy in the study and treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Cell death and associated c-jun induction in perinatal hypoxia-ischemia. Effect of the neuroprotective drug dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoids reduce ischemia-reperfusion-induced myocardial apoptosis in immature hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Hormonal modification in the treatment of disseminated cancer of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Adrenal steroids and the pattern of metastases of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

The influence of corticoid steroids on the frequency of spleen metastases in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoid administration in antiemetic therapy: is it safe?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Increased serum cortisol levels are associated with high tumour grade in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Corticosteroid-induced chemotherapy resistance in urological cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Dexamethasone pre-treatment interferes with apoptotic death in glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Dexamethasone prevents apoptosis in a neonatal rat model of hypoxic-ischemic encephalopathy (HIE) by a reactive oxygen species-independent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Steroid antiemesis may be harmful

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoid administration in antiemetic therapy: Is it safe?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Cancer dormancy: opportunities for new therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

The pathogenesis of cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Cortisone-induced metastases of adenocarcinoma in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Cortisone and calcium balance; effect of calcium, vitamin-D and methylandrostenediol.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Action of cortisone on disseminated tumor cells after removal of the primary growth

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Glucocorticoid hormones reduce the expression of major histocompatibility class I antigens on human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Dexamethasone used as an antiemetic in chemotherapy protocols inhibits natural cytotoxic (NC) cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

Tumorigenicity and lysis by natural killers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

A rapid in vitro screening system for the identification and evaluation of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970694-5

7 January 2021

10.1016/S1470-2045(06)70694-5

Identifiers

DOI

1 reference

14 August 2017

1 reference